Business Potential for Agricultural Biotechnology - Asian Productivity ...
Business Potential for Agricultural Biotechnology - Asian Productivity ...
Business Potential for Agricultural Biotechnology - Asian Productivity ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Commercialization of <strong>Agricultural</strong> Crop <strong>Biotechnology</strong> Products<br />
ment whereby conventional foods that have a history of safe use and consumption serve as a<br />
reference point <strong>for</strong> all safety testing.<br />
Testing <strong>for</strong> Food and Feed Safety<br />
Be<strong>for</strong>e any food crop produced using modern biotechnology can be marketed, the food<br />
product must undergo multiple years of rigorous safety assessment. In meeting stringent food<br />
safety requirements and standards, biotech foods are among the most thoroughly tested foods<br />
available. No other food crops in history—including foods currently available on grocers’<br />
shelves—have been tested and regulated as thoroughly as have foods developed through biotechnology.<br />
The safety of these foods is reviewed by regulatory agencies around the world according<br />
to internationally agreed-upon safety assessment guidelines.<br />
Data are collected systematically to assess food safety. The five main categories of testing<br />
are the safety of the new trait (most often the introduced protein), a comparison of the agronomic<br />
characteristics of the new plant to conventionally bred plants, also called “agronomic equivalence,”<br />
a comparison of the nutritional and biochemical composition of the new food with conventional<br />
food, also called “compositional equivalence,” the safety of the resulting food or feed<br />
established by comparative animal feeding studies, and the nutritional wholesomeness of the<br />
new food or feed established by testing in farm animals.<br />
Safety of the new trait (introduced protein). The safety assessment of products derived<br />
through biotechnology is unique in that the DNA inserted into the plant is well defined and well<br />
characterized. There<strong>for</strong>e, the newly produced protein(s) will be clearly identified. It is also<br />
important that the new substance produced in most biotech crops is a protein because very few<br />
proteins are harmful to humans and the specific protein(s) produced can be directly assessed <strong>for</strong><br />
safety.<br />
Each introduced protein is extensively characterized to understand how it functions and<br />
assess its similarity to proteins already present in foods. For example, the protein used to confer<br />
tolerance to Monsanto’s Roundup® herbicide, a member of a family of proteins present in most<br />
foods, has a well-defined function and is “generally recognized as safe” due to its history of safe<br />
consumption. The amount of the introduced protein is measured in key raw agricultural commodities<br />
to evaluate consumption levels and patterns. Comparison of the amino acid sequence of<br />
the introduced protein(s) to known toxins and allergens assures that the protein is neither a toxin<br />
nor an allergen nor closely related to either.<br />
Since proteins are a key component in food and are typically rapidly digested, the digestibility<br />
of the protein plays an important role in predicting safety. All proteins that have been introduced<br />
into biotech crops have been rapidly digested. To assess the potential to cause harm,<br />
animal toxicology studies are conducted with each new protein at high levels (thousands to hundreds<br />
of thousands of times greater than the highest predicted consumption). Not surprisingly,<br />
given the nature and digestibility of proteins used as well as the history of safe consumption, no<br />
adverse effects have been observed in these studies.<br />
The likelihood of the protein being an allergen or becoming an allergen is commonly<br />
assessed in detail according to international standards. The proteins used in commercial crops<br />
share none of the important characteristics that are common among known allergenic protein:<br />
none of these proteins is derived from allergenic sources or related to known allergens, the<br />
proteins are rapidly digested, and they are produced at low levels in the portions of the plant that<br />
are consumed. There<strong>for</strong>e, it has been concluded that these proteins pose no significant allergenic<br />
concerns.<br />
Agronomic equivalence. As part of the overall safety assessment of a crop developed via<br />
biotechnology, numerous agronomic and phenotypic parameters of the crop are compared with<br />
those of its conventional counterpart to assure that there are no meaningful changes caused by<br />
the trans<strong>for</strong>mation process or the introduced genes or trait. The morphology, yield, and other<br />
agronomic parameters are sensitive indicators of changes in the metabolism or physiology of the<br />
– 77 –